When administering sodium polystyrene sulfonate for hyperkalemia, which action should the nurse take?

Sodium polystyrene sulfonate is a medication used to treat hyperkalemia by exchanging sodium for potassium in the intestines, which lowers serum potassium levels. One of the significant side effects associated with this medication is constipation, which can occur due to the sodium content and the resin's effects on gastrointestinal motility. Therefore, monitoring the client for signs of constipation is a crucial nursing intervention to ensure that the patient remains comfortable and to prevent more severe complications that can arise from this side effect.

The concern for constipation is particularly important in this context, as severe constipation can lead to bowel obstruction and other gastrointestinal complications. By observing for any symptoms of constipation, such as abdominal pain, bloating, or infrequent bowel movements, the nurse can intervene promptly, ensuring patient safety and well-being during treatment with sodium polystyrene sulfonate.

While other actions might relate to the medication's administration or effects, monitoring for constipation directly addresses a potentially serious side effect and is a critical part of patient care when handling this medication.